Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Approves Paxlovid for COVID-19

The FDA estimates Paxlovid could save 1,500 lives and prevent 13,000 hospitalizations each week in the United States.

Reuters
Reuters

According to a recent NBC News article, the FDA has granted full approval to Pfizer’s antiviral pill, Paxlovid. The pill is specifically intended for adults over 50 and individuals with medical conditions that make them more susceptible to severe illness or death from COVID-19. The FDA's decision comes after clinical data proved the safety and effectiveness of the drug. It consists of two medications, nirmatrelvir and ritonavir, that work in tandem to block a key enzyme the virus needs to replicate and boost the body's ability to fight the infection. 

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging